| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB3 HK2 CRIM1 PDGFRA MAP3K14 DGKD DGKH CDC42BPB ITK PTK2B MAP4K5 CCL2 EIF2AK4 ATM | 9.21e-06 | 709 | 98 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B DNHD1 ATP6V0B RNF213 ATP10B FANCM MSH6 ATP2C1 MACF1 ATP13A3 MYO15A DNAH6 SMC1B | 9.47e-06 | 614 | 98 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB3 HK2 CRIM1 PDGFRA MAP3K14 DGKD DGKH CDC42BPB ITK PTK2B MAP4K5 CCL2 EIF2AK4 ATM POLK MAB21L1 | 1.25e-05 | 938 | 98 | 16 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | EPHB3 HK2 CRIM1 PDGFRA MAP3K14 DGKD DGKH CDC42BPB ITK PTK2B MAP4K5 CCL2 EIF2AK4 ATM | 2.12e-05 | 764 | 98 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB3 CRIM1 PDGFRA MAP3K14 CDC42BPB ITK PTK2B MAP4K5 CCL2 EIF2AK4 ATM | 1.73e-04 | 600 | 98 | 11 | GO:0004672 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.20e-04 | 441 | 98 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.28e-04 | 36 | 98 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.28e-04 | 36 | 98 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.44e-04 | 145 | 98 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX19B GTPBP4 MTG1 RNF213 ATP10B FANCM ATP2C1 MACF1 PLPP4 ATP13A3 DNAH6 SMC1B | 8.23e-04 | 839 | 98 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX19B GTPBP4 MTG1 RNF213 ATP10B FANCM ATP2C1 MACF1 PLPP4 ATP13A3 DNAH6 SMC1B | 8.32e-04 | 840 | 98 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX19B GTPBP4 MTG1 RNF213 ATP10B FANCM ATP2C1 MACF1 PLPP4 ATP13A3 DNAH6 SMC1B | 8.32e-04 | 840 | 98 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | lipid kinase activity | 1.07e-03 | 41 | 98 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 1.27e-03 | 11 | 98 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19B GTPBP4 MTG1 RNF213 ATP10B FANCM ATP2C1 MACF1 ATP13A3 DNAH6 SMC1B | 1.46e-03 | 775 | 98 | 11 | GO:0017111 |
| Domain | CTNNB1_binding | 1.66e-04 | 4 | 99 | 2 | PF08347 | |
| Domain | TCF/LEF | 1.66e-04 | 4 | 99 | 2 | IPR024940 | |
| Domain | CTNNB1-bd_N | 1.66e-04 | 4 | 99 | 2 | IPR013558 | |
| Domain | Mab-21-like_1/2 | 2.75e-04 | 5 | 99 | 2 | IPR020950 | |
| Domain | Kinase-like_dom | EPHB3 PDGFRA MAP3K14 CDC42BPB ITK PTK2B MAP4K5 MACF1 EIF2AK4 ATM | 6.01e-04 | 542 | 99 | 10 | IPR011009 |
| Domain | ATPase_P-typ_P_site | 9.08e-04 | 36 | 99 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 9.08e-04 | 36 | 99 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 9.08e-04 | 36 | 99 | 3 | PS00154 | |
| Domain | Protein_kinase_ATP_BS | 9.17e-04 | 379 | 99 | 8 | IPR017441 | |
| Domain | ATPase_P-typ_transduc_dom_A | 9.85e-04 | 37 | 99 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 9.85e-04 | 37 | 99 | 3 | PF00122 | |
| Domain | DAGK_acc | 1.22e-03 | 10 | 99 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 1.22e-03 | 10 | 99 | 2 | IPR000756 | |
| Domain | DAGKa | 1.22e-03 | 10 | 99 | 2 | SM00045 | |
| Domain | Tyr_kinase_cat_dom | 1.23e-03 | 88 | 99 | 4 | IPR020635 | |
| Domain | TyrKc | 1.23e-03 | 88 | 99 | 4 | SM00219 | |
| Domain | fn3 | 1.71e-03 | 162 | 99 | 5 | PF00041 | |
| Domain | PROTEIN_KINASE_TYR | 1.77e-03 | 97 | 99 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.77e-03 | 97 | 99 | 4 | IPR008266 | |
| Domain | Mab-21 | 1.77e-03 | 12 | 99 | 2 | PF03281 | |
| Domain | Mab-21 | 1.77e-03 | 12 | 99 | 2 | SM01265 | |
| Domain | Quinoprot_gluc/sorb_DH | 1.77e-03 | 12 | 99 | 2 | IPR011041 | |
| Domain | Mab-21_dom | 1.77e-03 | 12 | 99 | 2 | IPR024810 | |
| Domain | FERM_M | 1.86e-03 | 46 | 99 | 3 | PF00373 | |
| Domain | FERM_central | 2.23e-03 | 49 | 99 | 3 | IPR019748 | |
| Domain | FERM_domain | 2.23e-03 | 49 | 99 | 3 | IPR000299 | |
| Domain | FERM_1 | 2.36e-03 | 50 | 99 | 3 | PS00660 | |
| Domain | FERM_2 | 2.36e-03 | 50 | 99 | 3 | PS00661 | |
| Domain | FERM_3 | 2.36e-03 | 50 | 99 | 3 | PS50057 | |
| Domain | Band_41_domain | 2.36e-03 | 50 | 99 | 3 | IPR019749 | |
| Domain | B41 | 2.36e-03 | 50 | 99 | 3 | SM00295 | |
| Domain | Dynein_HC_stalk | 2.43e-03 | 14 | 99 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.43e-03 | 14 | 99 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.43e-03 | 14 | 99 | 2 | PF08393 | |
| Domain | MT | 2.43e-03 | 14 | 99 | 2 | PF12777 | |
| Domain | DAGKc | 2.43e-03 | 14 | 99 | 2 | SM00046 | |
| Domain | CNH | 2.43e-03 | 14 | 99 | 2 | SM00036 | |
| Domain | DHC_fam | 2.79e-03 | 15 | 99 | 2 | IPR026983 | |
| Domain | Diacylglycerol_kinase_cat_dom | 2.79e-03 | 15 | 99 | 2 | IPR001206 | |
| Domain | DAGK | 2.79e-03 | 15 | 99 | 2 | PS50146 | |
| Domain | Dynein_heavy | 2.79e-03 | 15 | 99 | 2 | PF03028 | |
| Domain | DAGK_cat | 2.79e-03 | 15 | 99 | 2 | PF00781 | |
| Domain | CNH | 2.79e-03 | 15 | 99 | 2 | PF00780 | |
| Domain | Dynein_heavy_dom | 2.79e-03 | 15 | 99 | 2 | IPR004273 | |
| Domain | CNH | 2.79e-03 | 15 | 99 | 2 | PS50219 | |
| Domain | CNH_dom | 2.79e-03 | 15 | 99 | 2 | IPR001180 | |
| Domain | PROTEIN_KINASE_ATP | 3.05e-03 | 459 | 99 | 8 | PS00107 | |
| Domain | FN3 | 3.05e-03 | 185 | 99 | 5 | SM00060 | |
| Domain | C1_1 | 3.44e-03 | 57 | 99 | 3 | PF00130 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.59e-03 | 17 | 99 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.59e-03 | 17 | 99 | 2 | PF00689 | |
| Domain | NAD/diacylglycerol_kinase | 3.59e-03 | 17 | 99 | 2 | IPR016064 | |
| Domain | Cation_ATPase_N | 4.03e-03 | 18 | 99 | 2 | PF00690 | |
| Domain | FN3 | 4.16e-03 | 199 | 99 | 5 | PS50853 | |
| Domain | Prot_kinase_dom | 4.46e-03 | 489 | 99 | 8 | IPR000719 | |
| Domain | GTP_binding_domain | 4.48e-03 | 19 | 99 | 2 | IPR006073 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.48e-03 | 19 | 99 | 2 | IPR004014 | |
| Domain | PROTEIN_KINASE_DOM | 4.68e-03 | 493 | 99 | 8 | PS50011 | |
| Domain | ZF_DAG_PE_1 | 4.76e-03 | 64 | 99 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 4.76e-03 | 64 | 99 | 3 | PS50081 | |
| Domain | Pkinase_Tyr | 4.93e-03 | 129 | 99 | 4 | PF07714 | |
| Domain | C1 | 4.97e-03 | 65 | 99 | 3 | SM00109 | |
| Domain | FN3_dom | 5.11e-03 | 209 | 99 | 5 | IPR003961 | |
| Domain | PE/DAG-bd | 5.19e-03 | 66 | 99 | 3 | IPR002219 | |
| Pubmed | ZBTB38 COL12A1 HK2 REPS1 DGKD CCDC141 CDC42BPB ZNF462 PHF1 AKTIP MACF1 MYOM2 | 1.91e-08 | 497 | 99 | 12 | 23414517 | |
| Pubmed | 2.80e-07 | 225 | 99 | 8 | 12168954 | ||
| Pubmed | 7.77e-07 | 7 | 99 | 3 | 10556287 | ||
| Pubmed | Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung. | 3.63e-06 | 11 | 99 | 3 | 11731265 | |
| Pubmed | Identification and characterization of two splice variants of human diacylglycerol kinase eta. | 8.02e-06 | 2 | 99 | 2 | 12810723 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24463962 | ||
| Pubmed | A gene family of HMG-box transcription factors with homology to TCF-1. | 8.02e-06 | 2 | 99 | 2 | 1741298 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11857508 | ||
| Pubmed | The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development. | 8.02e-06 | 2 | 99 | 2 | 27558071 | |
| Pubmed | Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. | 8.02e-06 | 2 | 99 | 2 | 9916915 | |
| Pubmed | Genomic cloning and chromosomal localization of the mouse Mab21l2 locus. | 8.02e-06 | 2 | 99 | 2 | 10516425 | |
| Pubmed | A PiggyBac-based recessive screening method to identify pluripotency regulators. | 8.02e-06 | 2 | 99 | 2 | 21533166 | |
| Pubmed | 1.77e-05 | 18 | 99 | 3 | 19308021 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 17607356 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 25659031 | ||
| Pubmed | In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators. | 2.40e-05 | 3 | 99 | 2 | 24463605 | |
| Pubmed | UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors. | 2.40e-05 | 3 | 99 | 2 | 30612738 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 23949095 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 34525377 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 32403323 | ||
| Pubmed | Genome-wide interrogation of longitudinal FEV1 in children with asthma. | 2.40e-05 | 3 | 99 | 2 | 25221879 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 19805521 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 18954908 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20532534 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 26789250 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 7947467 | ||
| Pubmed | Local retinoic acid signaling directs emergence of the extraocular muscle functional unit. | 2.46e-05 | 20 | 99 | 3 | 33201874 | |
| Pubmed | 2.46e-05 | 20 | 99 | 3 | 29084951 | ||
| Pubmed | Identification of myosin II as a binding protein to the PH domain of protein kinase B. | 4.79e-05 | 4 | 99 | 2 | 10082674 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 28928376 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 33587034 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 20361036 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 22951069 | ||
| Pubmed | Mapping canonical Wnt signaling in the developing and adult retina. | 4.79e-05 | 4 | 99 | 2 | 17065530 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 19942750 | ||
| Pubmed | 5.26e-05 | 230 | 99 | 6 | 35449600 | ||
| Pubmed | 5.55e-05 | 26 | 99 | 3 | 25810530 | ||
| Pubmed | GTPBP4 TCF7L2 HK2 REPS1 VPS45 MAP3K14 RNF213 MAB21L2 MSH6 AKTIP EIF2B3 IPO13 ATP13A3 ATM | 5.78e-05 | 1440 | 99 | 14 | 30833792 | |
| Pubmed | ZBTB38 REPS1 CRIM1 VPS45 UBQLN4 OBSL1 CDC42BPB CFAP298 SUPT5H HPF1 MACF1 TLN2 ATM | 7.30e-05 | 1285 | 99 | 13 | 35914814 | |
| Pubmed | 7.50e-05 | 78 | 99 | 4 | 17192257 | ||
| Pubmed | Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. | 7.98e-05 | 5 | 99 | 2 | 21285352 | |
| Pubmed | MAB21L1 modulates gene expression and DNA metabolic processes in the lens placode. | 7.98e-05 | 5 | 99 | 2 | 34779479 | |
| Pubmed | Mouse CCDC79 (TERB1) is a meiosis-specific telomere associated protein. | 7.98e-05 | 5 | 99 | 2 | 24885367 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TCF7L2 VPS45 RNF213 DGKH CDC42BPB C2CD2 ZNF462 DOCK5 ATP2C1 MACF1 EIF2AK4 SPATS2 POLK SMG6 | 8.25e-05 | 1489 | 99 | 14 | 28611215 |
| Pubmed | 8.54e-05 | 493 | 99 | 8 | 15368895 | ||
| Pubmed | 9.55e-05 | 83 | 99 | 4 | 11114734 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 9488439 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 17601994 | ||
| Pubmed | An evolutionarily conserved nested gene pair - Mab21 and Lrba/Nbea in metazoan. | 1.19e-04 | 6 | 99 | 2 | 19482073 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 23152144 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 11731231 | ||
| Pubmed | NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity. | 1.19e-04 | 6 | 99 | 2 | 33398181 | |
| Pubmed | Dazap2 modulates transcription driven by the Wnt effector TCF-4. | 1.19e-04 | 6 | 99 | 2 | 19304756 | |
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 1.62e-04 | 37 | 99 | 3 | 35831952 | |
| Pubmed | Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. | 1.67e-04 | 7 | 99 | 2 | 12727872 | |
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 24038355 | ||
| Pubmed | MCM9 deficiency delays primordial germ cell proliferation independent of the ATM pathway. | 1.67e-04 | 7 | 99 | 2 | 26388201 | |
| Pubmed | Common variants in the GDF5-UQCC region are associated with variation in human height. | 1.67e-04 | 7 | 99 | 2 | 18193045 | |
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 11528125 | ||
| Pubmed | β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells. | 1.67e-04 | 7 | 99 | 2 | 32820720 | |
| Pubmed | RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. | 1.67e-04 | 7 | 99 | 2 | 18772112 | |
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 19303461 | ||
| Pubmed | 2.04e-04 | 101 | 99 | 4 | 9872452 | ||
| Pubmed | 2.22e-04 | 8 | 99 | 2 | 21177349 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 2.22e-04 | 8 | 99 | 2 | 14667415 | |
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 2.22e-04 | 8 | 99 | 2 | 32179550 | |
| Pubmed | 2.85e-04 | 9 | 99 | 2 | 25010009 | ||
| Pubmed | Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. | 2.85e-04 | 9 | 99 | 2 | 17335794 | |
| Pubmed | 2.85e-04 | 9 | 99 | 2 | 12101254 | ||
| Pubmed | Role and regulation of PDGFRα signaling in liver development and regeneration. | 2.85e-04 | 9 | 99 | 2 | 23529017 | |
| Pubmed | 2.85e-04 | 9 | 99 | 2 | 24840331 | ||
| Pubmed | 2.85e-04 | 9 | 99 | 2 | 29867988 | ||
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 3.09e-04 | 205 | 99 | 5 | 12040188 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.31e-04 | 208 | 99 | 5 | 33230847 | |
| Pubmed | Genetic variants near PDGFRA are associated with corneal curvature in Australians. | 3.56e-04 | 10 | 99 | 2 | 22969067 | |
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 27177420 | ||
| Pubmed | Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. | 3.56e-04 | 10 | 99 | 2 | 19515974 | |
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 19851446 | ||
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 18498634 | ||
| Pubmed | A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. | 3.56e-04 | 10 | 99 | 2 | 22393260 | |
| Pubmed | The Oncogenic PRL Protein Causes Acid Addiction of Cells by Stimulating Lysosomal Exocytosis. | 3.75e-04 | 49 | 99 | 3 | 32918875 | |
| Pubmed | 4.10e-04 | 218 | 99 | 5 | 19460752 | ||
| Pubmed | Non-proteolytic ubiquitination of OTULIN regulates NF-κB signaling pathway. | 4.34e-04 | 11 | 99 | 2 | 31504727 | |
| Pubmed | Tcf7L2 is essential for neurogenesis in the developing mouse neocortex. | 4.34e-04 | 11 | 99 | 2 | 29751817 | |
| Pubmed | 4.34e-04 | 11 | 99 | 2 | 27605665 | ||
| Pubmed | Generation of a Mouse Model to Study the Noonan Syndrome Gene Lztr1 in the Telencephalon. | 4.34e-04 | 11 | 99 | 2 | 34222248 | |
| Pubmed | 4.34e-04 | 11 | 99 | 2 | 17021016 | ||
| Pubmed | SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. | 4.34e-04 | 11 | 99 | 2 | 11877377 | |
| Pubmed | 4.45e-04 | 222 | 99 | 5 | 37071664 | ||
| Pubmed | Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. | 5.20e-04 | 12 | 99 | 2 | 10631168 | |
| Pubmed | Wnt signalling induces maturation of Paneth cells in intestinal crypts. | 5.20e-04 | 12 | 99 | 2 | 15778706 | |
| Pubmed | 5.20e-04 | 12 | 99 | 2 | 32414917 | ||
| Pubmed | 5.20e-04 | 12 | 99 | 2 | 10783165 | ||
| Pubmed | 5.20e-04 | 12 | 99 | 2 | 19396169 | ||
| Pubmed | 5.20e-04 | 12 | 99 | 2 | 30604848 | ||
| Pubmed | Rescuing lung development through embryonic inhibition of histone acetylation. | 5.20e-04 | 12 | 99 | 2 | 38295182 | |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 5.20e-04 | 12 | 99 | 2 | 11266540 | |
| Pubmed | 5.23e-04 | 230 | 99 | 5 | 29513927 | ||
| Pubmed | Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. | 6.13e-04 | 13 | 99 | 2 | 19718027 | |
| Pubmed | Investigation of genes important in neurodevelopment disorders in adult human brain. | 6.13e-04 | 13 | 99 | 2 | 26194112 | |
| Cytoband | 2p16 | 3.00e-04 | 12 | 99 | 2 | 2p16 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 5.80e-04 | 10 | 66 | 2 | 1178 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 8.06e-04 | 50 | 66 | 3 | 1293 | |
| Coexpression | GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 2.27e-06 | 157 | 99 | 7 | M6871 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.63e-10 | 199 | 99 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.35e-06 | 156 | 99 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-06 | 175 | 99 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.99e-06 | 188 | 99 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.50e-06 | 192 | 99 | 6 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.92e-06 | 195 | 99 | 6 | b67d4f34cae729c18275486d3b20c9dd7d5cbe79 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-06 | 197 | 99 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-06 | 198 | 99 | 6 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-06 | 198 | 99 | 6 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-06 | 198 | 99 | 6 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-06 | 198 | 99 | 6 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.37e-06 | 198 | 99 | 6 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.37e-06 | 198 | 99 | 6 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 5.37e-06 | 198 | 99 | 6 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 5.69e-06 | 200 | 99 | 6 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.69e-06 | 200 | 99 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 5.69e-06 | 200 | 99 | 6 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 5.69e-06 | 200 | 99 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 149 | 99 | 5 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 2.58e-05 | 156 | 99 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 160 | 99 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 160 | 99 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.38e-05 | 165 | 99 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.38e-05 | 165 | 99 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-05 | 169 | 99 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.01e-05 | 171 | 99 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 4.12e-05 | 172 | 99 | 5 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.12e-05 | 172 | 99 | 5 | f3c16a62eba1ed190318beee131c71c5150b266a | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 4.12e-05 | 172 | 99 | 5 | fb8ab2576b5c38db63573a3bf46b8d9d634c4999 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.35e-05 | 174 | 99 | 5 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 4.47e-05 | 175 | 99 | 5 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 4.47e-05 | 175 | 99 | 5 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB|TCGA-Thymus / Sample_Type by Project: Shred V9 | 4.47e-05 | 175 | 99 | 5 | 50f9b994bdd389158f92f891944ea81b2fb15eef | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.85e-05 | 178 | 99 | 5 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.98e-05 | 179 | 99 | 5 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | C_00|World / shred on cell type and cluster | 4.98e-05 | 179 | 99 | 5 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.25e-05 | 181 | 99 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 5.53e-05 | 183 | 99 | 5 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-05 | 183 | 99 | 5 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 185 | 99 | 5 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.98e-05 | 186 | 99 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.98e-05 | 186 | 99 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-05 | 190 | 99 | 5 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 190 | 99 | 5 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.94e-05 | 192 | 99 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 192 | 99 | 5 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.94e-05 | 192 | 99 | 5 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.11e-05 | 193 | 99 | 5 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.11e-05 | 193 | 99 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.11e-05 | 193 | 99 | 5 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.11e-05 | 193 | 99 | 5 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 194 | 99 | 5 | 0ef63abcfd057079a9a6f8b27404ff521d44845d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.29e-05 | 194 | 99 | 5 | 46e522ca59db545d1eb0c27cd4361f19d4f8f762 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 194 | 99 | 5 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-05 | 195 | 99 | 5 | 43f0c257e4bb5c627afbdfc695c1199c672842d3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-05 | 195 | 99 | 5 | cd6cfe3ef150a4a4575e04fc8a8213cdceefa1c4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-05 | 195 | 99 | 5 | e22ca35bea06aa95ff2cc771632969f5e7229ffc | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 7.47e-05 | 195 | 99 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.65e-05 | 196 | 99 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | Control-Myeloid-Macrophage|Control / Disease state, Lineage and Cell class | 7.65e-05 | 196 | 99 | 5 | e2c2a30fa3ee3034fbde5335be169e880dde622d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.65e-05 | 196 | 99 | 5 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-05 | 196 | 99 | 5 | 97324c9e93f833e1f218e81fb53066d44c6892df | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.65e-05 | 196 | 99 | 5 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.65e-05 | 196 | 99 | 5 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.84e-05 | 197 | 99 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.84e-05 | 197 | 99 | 5 | c0250509836f1be04f5e54386191d7bb1e1da652 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.84e-05 | 197 | 99 | 5 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.84e-05 | 197 | 99 | 5 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.84e-05 | 197 | 99 | 5 | e92757e988888347c74286cc42c262b03159b0b9 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.84e-05 | 197 | 99 | 5 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.03e-05 | 198 | 99 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.03e-05 | 198 | 99 | 5 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|World / disease group, cell group and cell class | 8.03e-05 | 198 | 99 | 5 | 1d12be256af028c88e31fb535068bae16b7bd48e | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.03e-05 | 198 | 99 | 5 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.03e-05 | 198 | 99 | 5 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.03e-05 | 198 | 99 | 5 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.03e-05 | 198 | 99 | 5 | e8bfae3888b2406b5629b576cb02913b3297337e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.03e-05 | 198 | 99 | 5 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 8.22e-05 | 199 | 99 | 5 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.22e-05 | 199 | 99 | 5 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.22e-05 | 199 | 99 | 5 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.22e-05 | 199 | 99 | 5 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 200 | 99 | 5 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 200 | 99 | 5 | 79e59ab31d3d3385b1b072dc75508af9546c2e1b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 8.41e-05 | 200 | 99 | 5 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 8.41e-05 | 200 | 99 | 5 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 8.41e-05 | 200 | 99 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 200 | 99 | 5 | 873def69bf55ccbfc944bc10c5afc06be019c312 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.64e-04 | 123 | 99 | 4 | 5f002f5180fe47fe57ab888b5f0319df99ab2c59 | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.47e-06 | 198 | 99 | 8 | 5532_DN | |
| Drug | Artemisinin [63968-64-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 2.57e-06 | 199 | 99 | 8 | 7247_DN | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A | 2.40e-05 | 196 | 99 | 7 | 2158_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.40e-05 | 196 | 99 | 7 | 4815_DN | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 7463_DN | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 3308_DN | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; HL60; HG-U133A | 2.56e-05 | 198 | 99 | 7 | 1560_DN | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; MCF7; HT_HG-U133A_EA | 2.56e-05 | 198 | 99 | 7 | 881_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.65e-05 | 199 | 99 | 7 | 6804_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; HL60; HG-U133A | 2.65e-05 | 199 | 99 | 7 | 1424_UP | |
| Drug | lanthanum | 2.89e-05 | 136 | 99 | 6 | CID000023926 | |
| Disease | myeloid white cell count | TCF7L2 MAP3K14 UBQLN4 DGKH HNF4A PTK2B SUPT5H GLG1 MAP4K5 TLN2 AKAP11 DTHD1 TCF7L1 SMG6 | 2.64e-06 | 937 | 98 | 14 | EFO_0007988 |
| Disease | Tuberculosis, Pulmonary | 3.27e-05 | 3 | 98 | 2 | C0041327 | |
| Disease | bone density | 4.67e-05 | 388 | 98 | 8 | EFO_0003923 | |
| Disease | total blood protein measurement | 1.29e-04 | 449 | 98 | 8 | EFO_0004536 | |
| Disease | diabetic angiopathy (implicated_via_orthology) | 1.62e-04 | 6 | 98 | 2 | DOID:11713 (implicated_via_orthology) | |
| Disease | nephrolithiasis | 1.80e-04 | 33 | 98 | 3 | EFO_0004253 | |
| Disease | neutrophil percentage of leukocytes | 2.00e-04 | 610 | 98 | 9 | EFO_0007990 | |
| Disease | Thyroid Gland Follicular Adenoma | 2.15e-04 | 35 | 98 | 3 | C0151468 | |
| Disease | pulmonary function measurement, forced expiratory volume | 2.54e-04 | 37 | 98 | 3 | EFO_0003892, EFO_0004314 | |
| Disease | Thyroid Neoplasm | 2.54e-04 | 37 | 98 | 3 | C0040136 | |
| Disease | hemoglobin A1 measurement | 3.46e-04 | 520 | 98 | 8 | EFO_0007629 | |
| Disease | level of Sterol ester (27:1/16:1) in blood serum | 3.87e-04 | 9 | 98 | 2 | OBA_2045190 | |
| Disease | Thyroid carcinoma | 4.26e-04 | 44 | 98 | 3 | C0549473 | |
| Disease | MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) | 4.83e-04 | 10 | 98 | 2 | C1834752 | |
| Disease | Mycobacterium tuberculosis, susceptibility to | 4.83e-04 | 10 | 98 | 2 | cv:C1834752 | |
| Disease | MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO | 4.83e-04 | 10 | 98 | 2 | 607948 | |
| Disease | level of Sterol ester (27:1/18:3) in blood serum | 4.83e-04 | 10 | 98 | 2 | OBA_2045193 | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 4.83e-04 | 10 | 98 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 5.89e-04 | 11 | 98 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 6.59e-04 | 51 | 98 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | red blood cell density measurement | TCF7L2 MFSD2B HNF4A ZNF462 BRF1 MAP4K5 EIF2AK4 MYO15A TTC33 SMG6 | 6.95e-04 | 880 | 98 | 10 | EFO_0007978 |
| Disease | Influenza | 6.98e-04 | 52 | 98 | 3 | C0021400 | |
| Disease | Spina Bifida | 7.05e-04 | 12 | 98 | 2 | C0080178 | |
| Disease | Status Dysraphicus | 7.05e-04 | 12 | 98 | 2 | C0038219 | |
| Disease | microphthalmia (implicated_via_orthology) | 7.05e-04 | 12 | 98 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | Rachischisis | 7.05e-04 | 12 | 98 | 2 | C0266508 | |
| Disease | Cardiotoxicity | 8.32e-04 | 13 | 98 | 2 | C0876994 | |
| Disease | vascular endothelial growth factor measurement | 8.67e-04 | 56 | 98 | 3 | EFO_0004762 | |
| Disease | platelet component distribution width | 9.29e-04 | 755 | 98 | 9 | EFO_0007984 | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 9.68e-04 | 14 | 98 | 2 | C1150929 | |
| Disease | cholesterol to total lipids in IDL percentage | 1.06e-03 | 60 | 98 | 3 | EFO_0022233 | |
| Disease | urolithiasis | 1.22e-03 | 63 | 98 | 3 | MONDO_0024647 | |
| Disease | phospholipid measurement | 1.24e-03 | 140 | 98 | 4 | EFO_0004639 | |
| Disease | migraine disorder | 1.24e-03 | 357 | 98 | 6 | MONDO_0005277 | |
| Disease | – | 1.27e-03 | 16 | 98 | 2 | 609423 | |
| Disease | Susceptibility to HIV infection | 1.27e-03 | 16 | 98 | 2 | cv:C1836230 | |
| Disease | Intrahepatic cholestasis of pregnancy | 1.27e-03 | 16 | 98 | 2 | EFO_0009048 | |
| Disease | leptin measurement, type 2 diabetes mellitus | 1.27e-03 | 16 | 98 | 2 | EFO_0005000, MONDO_0005148 | |
| Disease | breast carcinoma (is_marker_for) | 1.40e-03 | 66 | 98 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Familial primary pulmonary hypertension | 1.44e-03 | 17 | 98 | 2 | C0340543 | |
| Disease | diabetes mellitus | 1.52e-03 | 68 | 98 | 3 | EFO_0000400 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.59e-03 | 69 | 98 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | fasting blood insulin measurement | 1.59e-03 | 69 | 98 | 3 | EFO_0004466 | |
| Disease | serum hepcidin measurement | 1.61e-03 | 18 | 98 | 2 | EFO_0004504 | |
| Disease | migraine disorder, systolic blood pressure | 1.61e-03 | 18 | 98 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | Cholecystitis | 1.80e-03 | 19 | 98 | 2 | HP_0001082 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.94e-03 | 74 | 98 | 3 | EFO_0022280 | |
| Disease | exercise test | 2.00e-03 | 20 | 98 | 2 | EFO_0004328 | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.00e-03 | 20 | 98 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | neutrophil count | VPS45 UBQLN4 DGKH HNF4A SUPT5H GLG1 MAP4K5 TLN2 AKAP11 DTHD1 TCF7L1 SMG6 | 2.09e-03 | 1382 | 98 | 12 | EFO_0004833 |
| Disease | complex trait | 2.13e-03 | 271 | 98 | 5 | EFO_0010578 | |
| Disease | triacylglycerol 54:6 measurement | 2.42e-03 | 22 | 98 | 2 | EFO_0010424 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.60e-03 | 82 | 98 | 3 | EFO_0008535 | |
| Disease | phosphatidylcholine measurement | 2.61e-03 | 284 | 98 | 5 | EFO_0010226 | |
| Disease | gestational diabetes | 2.64e-03 | 23 | 98 | 2 | EFO_0004593 | |
| Disease | BMI-adjusted fasting blood glucose measurement | 2.64e-03 | 23 | 98 | 2 | EFO_0008036 | |
| Disease | Pseudoaphakia | 2.87e-03 | 24 | 98 | 2 | C0524524 | |
| Disease | Lens Opacities | 2.87e-03 | 24 | 98 | 2 | C1510497 | |
| Disease | lipoprotein measurement, phospholipid measurement | 2.88e-03 | 85 | 98 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | unipolar depression, schizophrenia | 3.12e-03 | 25 | 98 | 2 | EFO_0003761, MONDO_0005090 | |
| Disease | fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement | 3.12e-03 | 25 | 98 | 2 | EFO_0004465, EFO_0004466, EFO_0004469 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGAVRVLCEIEKVVV | 986 | Q5DID0 | |
| TSDKVIAADCKRVTV | 1116 | Q86US8 | |
| VTEKLTRREVEAKFC | 1231 | Q9P2K8 | |
| VLKSSKVVRADVCVV | 411 | Q96NN9 | |
| KATCVRAAIKDCEVV | 56 | Q9H7F0 | |
| VVANKCDVKRIAELS | 286 | Q9BZE4 | |
| SKVVDSVKVCTARLF | 211 | Q9H8T0 | |
| CVIKERTVAQIKATV | 66 | Q8IXM2 | |
| EVITEAEKIAKVRNC | 1266 | Q9UKA4 | |
| ITACKEVGAQLVVIK | 281 | Q9NNX6 | |
| KIRALDTCKAVEAAE | 3781 | Q96M86 | |
| SSVCIVAEIIKKVER | 886 | P98194 | |
| TLCIAKKVVSEEDFR | 836 | O94823 | |
| SELATKCIIKIVEFA | 231 | P13631 | |
| ADLKRICKTIVEAAS | 246 | Q9NWY4 | |
| SLSTRCKVIVEVVDE | 326 | Q9Y5F8 | |
| VRVVSGAEAELKCVV | 21 | O75147 | |
| AKVEETIAVRCLAKN | 491 | P16234 | |
| LTDAIICARKIVKET | 106 | Q6UWQ5 | |
| DADLKRICKTIVEAA | 246 | A8MVJ9 | |
| ERHLKIKTCTVALDV | 3221 | Q9UKN7 | |
| FERICVIVEKDREKT | 1891 | Q8IYD8 | |
| SIIVKEVCTVVARRA | 816 | P52789 | |
| IRAKKIASIADVCES | 176 | P41235 | |
| ACDNVERVLKSVAVK | 261 | Q9BT17 | |
| VREFAKEIDVSCVKI | 621 | P54753 | |
| VCKQAEEVVVTLKVL | 446 | A6NFX1 | |
| KNKVRTRTVAECVAF | 306 | Q7Z3K6 | |
| EVTRDVIVRAADCKK | 1266 | Q9Y5S2 | |
| AVVISSAKTLCETVK | 506 | Q86XP1 | |
| VVKELAETIKCRTLF | 1231 | P52701 | |
| VRVKDGKVCVSAERE | 141 | Q14990 | |
| ICVVKIIRRTDKTEI | 66 | Q5VZY2 | |
| DSKAVVTCVIIVLSV | 316 | O95800 | |
| EKREVIVEESIRTCK | 2981 | Q9UPN3 | |
| VSVVSEKCRIDTEIL | 246 | Q9Y2X0 | |
| ELCSQKVFVSKVEAV | 416 | Q86Y26 | |
| VIVVTTRDVQKALCA | 51 | Q9NR50 | |
| KKKVDVVICLSTTVR | 771 | Q92896 | |
| TLVEDCVKVRSAAVT | 1721 | Q13315 | |
| CEAIKKVRDATGVDI | 366 | Q08462 | |
| AIISKKQVEAGVCVT | 121 | P57076 | |
| EVCIKVTIINFTVTK | 3181 | Q9C0G6 | |
| VSSVLRSAEEKVVVC | 116 | Q9Y426 | |
| VQAGDSKIVIAVIKC | 21 | Q6ZP82 | |
| ETVKVSIAIEEVTRC | 511 | Q9H7D0 | |
| KVQVECSRGVDIKAD | 426 | Q99715 | |
| KEAVIFKTIVAKEIC | 61 | P13500 | |
| EGKEKVLVTTNVCAR | 381 | Q9UMR2 | |
| ISVEKTVKRCLLDTF | 181 | Q9H0C8 | |
| LVSVDCKKGTRVQVD | 986 | Q9NZV1 | |
| VITIECSDKEKRVPF | 221 | Q6ZMT9 | |
| VLRSVSICTKVEEAF | 191 | Q5I0G3 | |
| AIAKTIREVCKVVSD | 26 | Q9Y586 | |
| IREVCKVVSDVLKEV | 31 | Q9Y586 | |
| ISSAKVLCETVKDFV | 501 | Q16760 | |
| VLCETVKDFVARVGK | 506 | Q16760 | |
| TKVVDVKCSNEAVLV | 196 | O95834 | |
| FKLVKCTVQTEIREI | 56 | Q14289 | |
| AKLKAAIAECEEVRR | 56 | P0CAP2 | |
| VVRKEVATVTKLCAE | 366 | Q9NVU0 | |
| FKICLVVTKEVSRDS | 46 | Q8NEC7 | |
| VVEAVCAIFEKSVKT | 701 | O94829 | |
| RDTVLVCLDKFVKIV | 736 | Q9Y4K4 | |
| CAVKKVRLEVFRAEE | 426 | Q99558 | |
| ELSRIKCVEIVKSDI | 56 | Q08881 | |
| VEKIFCASSRIAKVV | 1056 | A6NES4 | |
| IKKVDSAREVCLVQF | 51 | O43189 | |
| CDIESTKKVVVNGRV | 21 | Q96D71 | |
| AIAKTIREVCKVVSD | 26 | Q13394 | |
| IREVCKVVSDVLKEV | 31 | Q13394 | |
| KINVVSKCSAVKEEI | 506 | Q75T13 | |
| TVKCKIGEERATAIS | 181 | O00267 | |
| CSIKVTKVDETRGIA | 801 | Q8NHU6 | |
| KELSFARIKAVECVE | 51 | Q9Y5J5 | |
| CVQDDTAKAKITIVA | 106 | O15551 | |
| VAKTFEKCIIEAVSS | 991 | Q63HN8 | |
| EKVVVSRVARVCKND | 256 | Q9H3T3 | |
| VARFTCDVETLKKSI | 351 | Q86XZ4 | |
| GISVAKVNCVKEEIS | 76 | Q9P2K2 | |
| RAKVVAECTLKESAA | 361 | Q9HCS4 | |
| VVASEKVAKDCIRFL | 546 | Q8NDV3 | |
| CNEVTTVVDVKEIFK | 211 | Q6FHJ7 | |
| IKTKNLVSIIFCEAV | 86 | Q99437 | |
| AKVVAECTLKESAAI | 366 | Q9NQB0 | |
| KIKEISSVDCIALVD | 691 | Q9UBT6 | |
| IKASGTKEICVVRFT | 1261 | Q92576 | |
| SEAAKRLAECVKQVI | 181 | Q9NRW7 | |
| VKEVISVVKVCESTL | 246 | Q92994 | |
| DVCKIDSSGIVVKRF | 31 | Q8TBZ5 | |
| LIECARAVTEKVSLV | 1951 | Q9Y4G6 | |
| LKNETVAICVVTADK | 2481 | Q96JM2 | |
| ILCDVTIIVEDTKFK | 31 | Q8NAP3 | |
| VKCSKEVATAIRGAI | 141 | P15880 | |
| IVICDRASVKEFKEE | 26 | Q9NRR5 | |
| QACITAKIKESVIIS | 36 | Q8IYM9 | |
| SAKLAVVVTKTVDAC | 266 | Q8NA31 | |
| RVCPFKSEKVVVEDT | 926 | Q9UBN4 | |
| TVCEKRVVVLLDISA | 506 | A6NCI4 | |
| VVAAIQALEKKVDSC | 46 | Q6ZMS7 | |
| IVAVCAAIAEKEKTV | 211 | Q6PID6 | |
| ACERLQDAKTKVAIV | 596 | A6PVS8 | |
| EKETAVTKILRACTR | 721 | Q8IZF0 | |
| VRLVCKVANTKKETV | 1146 | P54296 |